Evogene Ltd (EVGN)
0.70
-0.01
(-1.89%)
USD |
NASDAQ |
May 07, 11:00
Evogene Price to Book Value: 2.940 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.996 |
| May 03, 2024 | 2.982 |
| May 02, 2024 | 2.963 |
| May 01, 2024 | 3.006 |
| April 30, 2024 | 2.936 |
| April 29, 2024 | 2.731 |
| April 26, 2024 | 2.626 |
| April 25, 2024 | 2.767 |
| April 24, 2024 | 2.812 |
| April 23, 2024 | 2.771 |
| April 22, 2024 | 2.730 |
| April 19, 2024 | 2.570 |
| April 18, 2024 | 2.691 |
| April 17, 2024 | 2.877 |
| April 16, 2024 | 2.94 |
| April 15, 2024 | 2.882 |
| April 12, 2024 | 3.120 |
| April 11, 2024 | 3.123 |
| April 10, 2024 | 3.256 |
| April 09, 2024 | 3.410 |
| April 08, 2024 | 3.314 |
| April 05, 2024 | 3.115 |
| April 04, 2024 | 3.108 |
| April 03, 2024 | 3.178 |
| April 02, 2024 | 3.178 |
| Date | Value |
|---|---|
| April 01, 2024 | 3.276 |
| March 28, 2024 | 3.15 |
| March 27, 2024 | 3.088 |
| March 26, 2024 | 3.066 |
| March 25, 2024 | 3.314 |
| March 22, 2024 | 3.331 |
| March 21, 2024 | 3.297 |
| March 20, 2024 | 3.361 |
| March 19, 2024 | 3.36 |
| March 18, 2024 | 3.398 |
| March 15, 2024 | 3.444 |
| March 14, 2024 | 3.213 |
| March 13, 2024 | 3.236 |
| March 12, 2024 | 3.437 |
| March 11, 2024 | 3.654 |
| March 08, 2024 | 3.906 |
| March 07, 2024 | 4.032 |
| March 06, 2024 | 3.900 |
| March 05, 2024 | 4.029 |
| March 04, 2024 | 4.059 |
| March 01, 2024 | 4.116 |
| February 29, 2024 | 3.827 |
| February 28, 2024 | 3.727 |
| February 27, 2024 | 3.717 |
| February 26, 2024 | 3.695 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3852
Minimum
Mar 18 2020
7.878
Maximum
Feb 11 2021
1.686
Average
1.167
Median
Price to Book Value Benchmarks
| Compugen Ltd | 2.950 |
| Pluri Inc | 6.725 |
| BioLine Rx Ltd | 4.202 |
| Can Fite Biofarma Ltd | 1.679 |
| BiomX Inc | 6.990 |
Price to Book Value Related Metrics
| PS Ratio | 5.669 |
| Price | 0.70 |
| Earnings Yield | -75.71% |
| Market Cap | 35.44M |